Hiroki Ikeuchi

Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis

Nobuyuki Kakiuchi, Kenichi Yoshida, Motoi Uchino et al. · Nature · 2019 · 245 citations

Inflammation, Frequent Mutations, Autoimmune Disease +9

Successful Chemotherapeutic Modality of Doxorubicin Plus Dacarbazine for the Treatment of Desmoid Tumors in Association With Familial Adenomatous Polyposis

Makoto Gega, Hidenori Yanagi, Reigetsu Yoshikawa et al. · Journal of Clinical Oncology · 2005 · 182 citations · Full text

Scheduled infliximab monotherapy to prevent recurrence of Crohnʼs disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

Kōji Yoshida, Ken Fukunaga, Hiroki Ikeuchi et al. · Inflammatory Bowel Diseases · 2011 · 151 citations · Full text

Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy

Yoshiko Takahashi, Yoshio Takesue, Kazuhiko Nakajima et al. · Journal of Infection and Chemotherapy · 2010 · 133 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +10

Bioresorbable Hyaluronate-Carboxymethylcellulose Membrane (Seprafilm) in Surgery for Rectal Carcinoma: A Prospective Randomized Clinical Trial

Masato Kusunoki, Hiroki Ikeuchi, Hidenori Yanagi et al. · Surgery Today · 2005 · 117 citations

Tissue Engineering, Surgical Oncology, Engineering +8